7/2/2014 9:55:18 AM
Cytori Therapeutics (NASDAQ: CYTX) today announced that the Company’s Board of Directors has appointed Gail K. Naughton, PhD to serve as an independent director, effective July 1, 2014.
“Dr. Naughton has a unique background in both development and commercialization of regenerative medicine and tissue-based products,” said Dr. Marc Hedrick, President and CEO of Cytori. “Her leadership qualities, specialized sector knowledge and deep industry connections will be valuable both in the board room and to our management team.”
Help employers find you! Check out all the jobs and post your resume.
comments powered by